Treatment of dislipemia in patients with metabolic syndrome or diabetes mellitus

被引：3

作者：

Millan, Jesus ^{[1
]}

机构：

[1] Univ Complutense, Med Interna Serv, Hosp Gen Univ Gregorio Maranon, Dept Med,Unidad Lipidos, Madrid 28007, Spain

来源：

MEDICINA CLINICA | 2007年 / 128卷 / 20期

关键词：

D O I：

10.1157/13106338

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：786 / 794

页数：9

共 64 条

[1] Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance [J].

Adeli, K ;

Taghibiglou, C ;

Van Iderstine, SC ;

Lewis, GF .

TRENDS IN CARDIOVASCULAR MEDICINE, 2001, 11 (05) :170-176

[2] NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older [J].

Alexander, CM ;

Landsman, PB ;

Teutsch, SM ;

Haffner, SM .

DIABETES, 2003, 52 (05) :1210-1214

[3]

[Anonymous], 2005, DIABETES CARE, V28, pS4

[4] Dietary approaches to prevent and treat hypertension - A scientific statement from the American Heart Association [J].

Appel, LJ ;

Brands, MW ;

Daniels, SR ;

Karanja, N ;

Elmer, PJ ;

Sacks, FM .

HYPERTENSION, 2006, 47 (02) :296-308

[5] A clinical trial of the effects of dietary patterns on blood pressure [J].

Appel, LJ ;

Moore, TJ ;

Obarzanek, E ;

Vollmer, WM ;

Svetkey, LP ;

Sacks, FM ;

Bray, GA ;

Vogt, TM ;

Cutler, JA ;

Windhauser, MM ;

Lin, PH ;

Karanja, N .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (16) :1117-1124

[6] Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids - Results of the OmniHeart randomized trial [J].

Appel, LJ ;

Sacks, FM ;

Carey, VJ ;

Obarzanek, E ;

Swain, JF ;

Miller, ER ;

Conlin, PR ;

Erlinger, TP ;

Rosner, BA ;

Laranjo, NM ;

Charleston, J ;

McCarron, P ;

Bishop, LM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (19) :2455-2464

[7] Significance of high density lipoprotein-cholesterol in cardiovascular risk prevention: Recommendations of HDL Forum [J].

Ascaso J.F. ;

Fernández-Cruz A. ;

González Santos P. ;

Hernández Mijares A. ;

Mangas Rojas A. ;

Millán J. ;

Pallardo L.F. ;

Pedro-Botet J. ;

Pérez-Jiménez F. ;

Pía G. ;

Pintó X. ;

Plaza I. ;

Rubiés-Prat J. .

American Journal of Cardiovascular Drugs, 2004, 4 (5) :299-314

[8] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].

Baigent, C ;

Keech, A ;

Kearney, PM ;

Blackwell, L ;

Buck, G ;

Pollicino, C ;

Kirby, A ;

Sourjina, T ;

Peto, R ;

Collins, R ;

Simes, J .

LANCET, 2005, 366 (9493) :1267-1278

[9]

CHAN DC, 2004, J DRUG EVALUATION, V1, P3

[10] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

← 1 2 3 4 5 6 7 →